J&J prostate cancer drug reduces risk of cancer spread and death in late-stage study

By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six ...
The New England Journal of Medicine

Perioperative Apalutamide in High-Risk Localized Prostate Cancer

Radical prostatectomy is potentially curative in patients with high-risk localized or locally advanced prostate cancer; however, relapse occurs within 5 years in up to 50% of patients. We ...
Health and Me on MSN

Why Thousands Of Black Men In The UK Are Now Being Invited For Prostate Cancer Screening?

The United Kingdom has invited thousands of black men to take part in prostate cancer screening. This step is taken to ...

Prostate cancer screening plan does not go far enough, experts warn

The Government’s plans for prostate cancer screening do not go far enough, experts have warned. James Murray, the new Health ...
STAT

For prostate cancer patients set on surgery, new hormone regimen may improve outcomes, study finds

By doing hormone therapy up front in prostate cancer cases, the hope was to shrink the relapse rate after surgery. Results ...

Prostate cancer screening: Final guidance recommends against testing all men

The majority of men in the UK will not be offered prostate cancer screening following a final recommendation from a committee ...

New practice guidance available for treatment of enlarged prostate

The Society of Interventional Radiology (SIR) has published new practice guidance for the use of prostatic artery ...